Stabilizing the stabilizer: Group psychoeducation enhances the stability of serum lithium levels

Bipolar Disorders, Supplement

Volumn 7, Issue 5, 2005, Pages 32-36

  Colom, F ^a,d   Vieta, Eduard ^a,b   Sanchez Moreno J ^a,c   Martinez Aran A ^a   Reinares, M ^a   Goikolea, J M ^a,b   Scott, J ^d  

^a Bipolar Disorders Program   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Bipolar disorder; Blood serum; Lithium; Patient non adherence; Psychotherapy

Indexed keywords

LITHIUM CARBONATE; MOOD STABILIZER;

ADULT; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; EDUCATION PROGRAM; FEMALE; HUMAN; LITHIUM BLOOD LEVEL; MALE; MENTAL PATIENT; OUTCOMES RESEARCH; PATIENT EDUCATION; PREDICTION; PRIORITY JOURNAL; PROPHYLAXIS; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SINGLE BLIND PROCEDURE;

ADULT; BIPOLAR DISORDER; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LITHIUM; MALE; PATIENT COMPLIANCE; PATIENT EDUCATION; PSYCHOTHERAPY; RECURRENCE; SINGLE-BLIND METHOD;

EID: 29544432650     PISSN: 13992406     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2005.00249.x     Document Type: Article

References (26)

1. Dunner DL, Stallone F, Fieve RR. Lithium carbonate and affective disorders. V: a double-blind study of prophylaxis of depression in bipolar illness. Arch Gen Psychiatry 1976; 33: 117-120.
2. Tondo L, Baldessarini RJ, Floris G. Long-term clinical effectiveness of lithium maintenance treatment in types I and II bipolar disorders. Br J Psychiatry Suppl 2001; 41: s184-s190.
3. Geddes JR, Burgess S, Hawton K, Jamison K, Goodwin GM. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry 2004; 161: 217-222.
4. Licht RW, Vestergaard P, Rasmussen NA, Jepsen K, Brodersen A, Hansen PE. A lithium clinic for bipolar patients: 2-year outcome of the first 148 patients. Acta Psychiatr Scand 2001; 104: 387-390.
5. Muller-Oerlinghausen B, Ahrens B, Volk J et al. Reduced mortality of manic-depressive patients in long-term lithium treatment: an international collaborative study by IGSLI. Psychiatry Res 1991; 36: 329-331.
6. Goodwin FK, Fireman B, Simon GE, Hunkeler EM, Lee J, Revicki D. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA 2003; 290: 1467-1473.
7. Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord 2002; 68: 167-181.
8. Coppen A, Standish-Barry H, Bailey J, Houston G, Silcocks P, Hermon C. Does lithium reduce the mortality of recurrent mood disorders? J Affect Disord 1991; 23: 1-7.
9. Isometsa E, Henriksson M, Lonnqvist J. completed suicide and recent lithium treatment. J Affect Disord 1992; 26: 101-103.
10. Solomon DA, Ristow WR, Keller MB et al. Serum lithium levels and psychosocial function in patients with bipolar I disorder. Am J Psychiatry 1996; 153: 1301-1307.
11. Perlis RH, Sachs GS, Lafer B et al. Effect of abrupt change from standard to low serum levels of lithium: a reanalysis of double-blind lithium maintenance data. Am J Psychiatry 2002; 159: 1155-1159.
12. Cavanagh J, Smyth R, Goodwin GM. Relapse into mania or depression following lithium discontinuation: a 7-year follow-up. Acta Psychiatr Scand 2004; 109: 91-95.
13. Maarbjerg K, Aagaard J, Vestergaard P. Adherence to lithium prophylaxis: I. Clinical predictors and patient's reasons for nonadherence. Pharmacopsychiatry 1988; 21: 121-125.
14. Schou M. The combat of non-compliance during prophylactic lithium treatment. Acta Psychiatr Scand 1997; 95: 361-363.
15. Kleindienst N, Greil W. Are illness concepts a powerful predictor of adherence to prophylactic treatment in bipolar disorder? J Clin Psychiatry 2004; 65: 966-974.
16. Scott J, Pope M. Nonadherence with mood stabilizers: prevalence and predictors. J Clin Psychiatry 2002; 63: 384-390.
17. Taylor R, Mallinger AG, Frank E, Rucci P, Thase ME, Kupfer DJ. Variability of erythrocyte and serum lithium levels correlates with therapist treatment adherence efforts and maintenance treatment outcome. Neuropsychopharmacology 2001; 24: 192-197.
18. Cochran SD. Preventing medical noncompliance in the outpatient treatment of bipolar affective disorders. J Consult Clin Psychol 1984; 52: 873-878.
19. Colom F, Vieta E, Martinez-Aran A et al. A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Arch Gen Psychiatry 2003; 60: 402-407.
20. Colom F, Vieta E, Martinez-Aran A, Reinares M, Benabarre A, Gasto C. Clinical factors associated with treatment noncompliance in euthymic bipolar patients. J Clin Psychiatry 2000; 61: 549-555.
21. Vieta E, Colom F. Psychological interventions in bipolar disorder: from wishful thinking to an evidence-based approach. Acta Psychiatr Scand Suppl 2004; 422: 34-38.
22. Vieta E. Improving treatment adherence in bipolar disorder through psychoeducation. J Clin Psychiatry 2005; 66 (Suppl. 1): 24-29.
23. Perry A, Tarrier N, Morriss R, McCarthy E, Limb K. Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment. BMJ 1999; 318: 149-153.
24. Gonzalez-Pinto A, Gonzalez C, Enjuto S et al. Psychoeducation and cognitive-behavioral therapy in bipolar disorder: an update. Acta Psychiatr Scand 2004; 109: 83-90.
25. Colom F, Vieta E. Non-adherence in psychiatric disorders: misbehaviour or clinical feature? Acta Psychiatr Scand 2002; 105: 161-163.
26. Colom F, Vieta E, Reinares M et al. Psychoeducation efficacy in bipolar disorders: beyond compliance enhancement. J Clin Psychiatry 2003; 64: 1101-1105.